Seeing Is Believing
Currently out of the existing stock ratings of Priyanka Grover, 4 are a BUY (100%).
Analyst Priyanka Grover, currently employed at JPMORGAN,
Priyanka Grover’s has documented 8 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RLAY, Relay Therapeutics at 14-Aug-2026.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$5
$3.13 (167.38%)
$7
1 years 3 months 15 days ago
(10-Jul-2025)
0/14 (0%)
$3.31 (195.86%)
Buy
$7
$5.13 (274.33%)
$7
1 years 7 months 7 days ago
(18-Mar-2025)
2/9 (22.22%)
$4.47 (176.68%)
339
Buy
$8
$6.13 (327.81%)
$8
2 years 4 months 5 days ago
(20-Jun-2024)
0/2 (0%)
$4.11 (105.66%)
Which stock is Priyanka Grover most bullish on?
Which stock is Priyanka Grover most reserved on?
What Year was the first public recommendation made by Priyanka Grover?